Login
$ILAG
$2.10 -$0.36 (14.63%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Accounts receivable
Inventories
Prepayments
Other receivables
Total current assets
NON-CURRENT ASSETS
Deposits
Property and equipment, net
Right-of-use assets, net
Total non-current assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Bank borrowings - current
Amount due to shareholders
Accounts payable
Advance from customers
Other payables and accruals
Taxes payable
Operating lease liabilities - current
Total current liabilities
NON-CURRENT LIABILITIES
Bank borrowings
Operating lease liabilities
Total non-current liabilities
Total liabilities
SHAREHOLDERS’ EQUITY
Ordinary shares, $0.001 par value; 450,000,000 shares authorized; 2,076,974 and 1,806,000 shares issued and outstanding as of December 31, 2025 and 2024
Preferred shares, value
Series A Preferred Stock
Series B Preferred Stock
Additional paid-in capital
Warrants
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support